Part 5/7:
The recent selloff in Gilead's stock—significant on the preceding Friday—has been characterized by some analysts as an overreaction. Stock valuation currently stands at roughly 7 to 8 times earnings, making it appear undervalued compared to traditional metrics, especially given the company's ability to stick to its full-year guidance. Management reaffirmed its guidance despite the softer quarter, signaling confidence in the company's long-term trajectory.